lanthanum has been researched along with calcitriol in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rhoten, WB; Sergeev, IN | 1 |
Brasitus, TA; Katnik, C; Nelson, DJ; Qasawa, BM; Sitrin, MD; Tien, XY | 1 |
Hutchison, AJ | 1 |
Albaaj, F; Hutchison, A | 1 |
Denton, J; Freemont, AJ; Hoyland, JA | 1 |
D'Haese, PC; De Broe, ME; Freemont, T; Gelev, S; Gill, M; Jones, C; Masin-Spasovska, J; Sikole, A; Spasovski, GB; Webster, I | 1 |
Fernandez Giraldez, E; Sánchez González, MC; Valdivielso Revilla, JM | 1 |
Malluche, HH; Mawad, H; Monier-Faugere, MC | 1 |
Hossack, S; Martin, P; Pierce, D; Poole, L; Robinson, A; Smyth, M; Van Heusen, H | 1 |
Anstey, CM; Gray, NA; Hollett, PR; Krishnasamy, R; Vardesh, DL | 1 |
Moe, SM; Moorthi, RN | 1 |
3 review(s) available for lanthanum and calcitriol
Article | Year |
---|---|
Hyperphosphataemia in renal failure: causes, consequences and current management.
Topics: Aluminum; Calcinosis; Calcitriol; Calcium; Cardiovascular Diseases; Chlorides; Epoxy Compounds; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Lanthanum; Magnesium; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Uronic Acids; Zirconium | 2003 |
[Control of phosphorus and treatment with vitamin D in chronic kidney disease prior to the start of dialysis].
Topics: Calcifediol; Calcinosis; Calcitriol; Cardiovascular Diseases; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney Diseases; Lanthanum; Phosphorus; Polyamines; Prevalence; Renal Dialysis; Sevelamer; Vitamin D; Vitamin D Deficiency | 2008 |
Effects of treatment of renal osteodystrophy on bone histology.
Topics: Bone and Bones; Bone Remodeling; Calcification, Physiologic; Calcitriol; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Lanthanum; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Sevelamer; Vitamin D | 2008 |
3 trial(s) available for lanthanum and calcitriol
Article | Year |
---|---|
The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Lanthanum; Male; Phosphorus; Renal Dialysis; Treatment Outcome | 2005 |
Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up.
Topics: Aged; Alkaline Phosphatase; Biomarkers; Calcifediol; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Follow-Up Studies; Humans; Ilium; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Treatment Outcome | 2006 |
The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol.
Topics: Administration, Oral; Adult; Calcitriol; Chelating Agents; Cross-Over Studies; Female; Humans; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Polyamines; Sevelamer; Tissue Distribution; Young Adult | 2011 |
5 other study(ies) available for lanthanum and calcitriol
Article | Year |
---|---|
1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line.
Topics: Animals; Caffeine; Calcitriol; Calcium; Calcium Channels; Cell Line; Islets of Langerhans; Lanthanum; Manganese; Nifedipine; Periodicity; Rats; Ryanodine; Terpenes; Thapsigargin | 1995 |
Characterization of the 1,25-dihydroxycholecalciferol-stimulated calcium influx pathway in CaCo-2 cells.
Topics: Calcitriol; Calcium; Calcium Channels; Calcium Radioisotopes; Cell Line; Electric Conductivity; Fluorometry; Humans; Lanthanum; Manganese; Tumor Cells, Cultured | 1993 |
Calcitriol, lanthanum carbonate, and other new phosphate binders in the management of renal osteodystrophy.
Topics: Calcitriol; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Lanthanum; Peritoneal Dialysis; Phosphates; Vitamin D | 1999 |
Impact of non-traditional phosphate binders and cinacalcet on haemodialysis patient biochemistry, pill burden and cost.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aluminum Hydroxide; Australia; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Costs; Female; Health Care Costs; Hemodialysis Units, Hospital; Humans; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2011 |
CKD-mineral and bone disorder: core curriculum 2011.
Topics: Bone Diseases; Calcinosis; Calciphylaxis; Calcitriol; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney; Kidney Failure, Chronic; Kidney Tubules; Lanthanum; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Vitamin D | 2011 |